BRYCE BLANTON: Open Payments
NPI 1356735880 · BERLIN, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$217 in 11 payments from 4 companies in 2025. Trend: 2023 $141 · 2024 $79 · 2025 $217
Food & beverage: $217
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 6 | $113 |
| Neurocrine BioSciences, Inc. | 3 | $59 |
| Lilly USA, LLC | 1 | $24 |
| Phathom Pharmaceuticals, Inc. | 1 | $21 |
Products named: VRAYLAR, INGREZZA, MOUNJARO, VOQUEZNA.
Industry payments across MD — which companies pay providers there.
